相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation
Michelle E. Farrell et al.
NEUROLOGY (2021)
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
Rema Raman et al.
JAMA NETWORK OPEN (2021)
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
Reisa A. Sperling et al.
JAMA NEUROLOGY (2020)
The search for Alzheimer disease therapeutics - same targets, better trials?
Michael S. Rafii et al.
NATURE REVIEWS NEUROLOGY (2020)
Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition
Ganna Leonenko et al.
ANNALS OF NEUROLOGY (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Subthreshold amyloid and its biological and clinical meaning Long way ahead
Gerard N. Bischof et al.
NEUROLOGY (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
Renaud La Joie et al.
ALZHEIMERS & DEMENTIA (2019)
The impact of amyloid-beta and tau on prospective cognitive decline in older individuals
Reisa A. Sperling et al.
ANNALS OF NEUROLOGY (2019)
Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
Zhuohao He et al.
NATURE MEDICINE (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
Michael C. Donohue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
Elizabeth C. Mormino et al.
ALZHEIMERS & DEMENTIA (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study
Nicolas Villain et al.
BRAIN (2012)
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ
Ola Philipson et al.
NEUROBIOLOGY OF AGING (2012)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
分享论文
